Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Supervisors: Prof Cathy Merry, Prof. Kenton Arkill, Dr Andrew Hook Overview Glycosaminoglycans (GAGs) are linear sugars that are displayed on all cells throughout the body as well as in the matrix
-
Support Grant of up to £5,000 Access to Disabled Student Allowance, paid sick leave and paid parental leave Supervisor: University of Warwick: Dr Arnab Palit, Prof Andy Metcalfe Eligibility: Satisfy UKRI's
-
internships at KU Leuven (Prof. Rodolphe Sepulchre) and at TU Delft (Prof. Charlotte Frenkel) Participate in yearly retreats organized by the doctoral network participants Support the dissemination of software
-
by Prof Anu Realo and Prof Kai Pata and is funded by the European Commission’s Horizon Europe “Widening Participation and Spreading Excellence” program. Running from 2025 to 2029, SustainERA will
-
22 Aug 2025 Job Information Organisation/Company Technische Universitaet Darmstadt Department Chemistry Research Field Chemistry » Physical chemistry Researcher Profile First Stage Researcher (R1
-
the fellow Prof J. L. Bamber, University of Bristol (https://research-information.bris.ac.uk/en/persons/jonathan-l-bamber), Prof X. Zhu (https://www.asg.ed.tum.de/en/sipeo/home/) and Dr M. Passaro in
-
a highly motivated candidate with: A first-class or upper second-class degree (or equivalent) in Materials Science, Chemistry, Physics, Chemical Engineering, or a related discipline. Experience in
-
Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg | Magdeburg, Sachsen Anhalt | Germany | 6 days ago
The Department of Process Systems Engineering (Director: Prof. Dr.-Ing. Kai Sundmacher) at the Max Planck Institute for Dynamics of Complex Technical Systems is inviting applications for the PhD
-
), preferably via the TUD SecureMail portal https://securemail.tu-dresden.de by sending it as a single pdf file toanton.wallner@tu-dresden.de or to: TU Dresden, Institute of Nuclear and Particle Physics,Prof
-
The vacancy is within the group of Associate Prof. Dr. Anna Salvati at the Department of Nanomedicine Drug Targeting of the Groningen Research Institute of Pharmacy (GRIP), Faculty of Science and